Clark Callahan N, Eby Elizabeth L, Lensing Cody J, Fultz Elena, Hart Brian, Lingcaro Lilian, Hoffner Ron, Schloot Nanette C, Benneyworth Brian D
Optum Labs, Eden Prairie, MN, 55344, USA.
Eli Lilly and Company, 1 Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Diabetes Ther. 2023 May;14(5):869-882. doi: 10.1007/s13300-023-01397-2. Epub 2023 Apr 1.
Effectively engaging people with type 2 diabetes (T2D) earlier in their health journeys is critical to prevent downstream complications. Digitally based diabetes programs are a growing component of care delivery that have the potential to engage individuals outside of traditional clinic-based settings and use personalized data to pair people to tailored diabetes self-management interventions. Knowing an individuals' diabetes empowerment and health-related motivation can help drive appropriate recommendations for personalized interventions. We aimed to characterize diabetes empowerment and motivation towards changing health behaviors among participants in Level2, a T2D specialty care organization in the USA that combines wearable technology with personalized clinical support.
A cross-sectional online survey was conducted among people enrolled in Level2 (February-March 2021). Distributions of respondent-reported diabetes empowerment and health motivation were analyzed using Motivation and Attitudes Toward Changing Health (MATCH) and Diabetes Empowerment Scale Short Form (DES-SF) scales, respectively. Associations between MATCH and DES-SF scores with Level2 engagement measures and glycemic control were analyzed.
The final analysis included 1258 respondents with T2D (mean age 55.7 ± 8.4 years). Respondents had high average MATCH (4.19/5) and DES-SF (4.02/5) scores. The average MATCH subscores for willingness (4.43/5) and worthwhileness (4.39/5) were higher than the average ability subscore (3.73/5). Both MATCH and DES-SF scores showed very weak correlations with Level2 engagement measures and glycemic control (ρ = - 0.18-0.19).
Level2 survey respondents had high average motivation and diabetes empowerment scores. Further research is needed to validate sensitivity of these scales to detect changes in motivation and empowerment over time and to determine whether differences in scores can be used to pair people to personalized interventions.
在2型糖尿病（T2D）患者的健康旅程早期有效地吸引他们参与进来对于预防下游并发症至关重要。基于数字技术的糖尿病项目在医疗服务中所占比重日益增加，它有可能让个体在传统诊所环境之外参与进来，并利用个性化数据为人们匹配量身定制的糖尿病自我管理干预措施。了解个体的糖尿病自我效能感和健康相关动机有助于为个性化干预提供恰当的建议。我们旨在描述美国一家将可穿戴技术与个性化临床支持相结合的T2D专科护理机构Level2的参与者中，糖尿病自我效能感以及改变健康行为的动机。
对Level2的注册人员（2021年2月至3月）进行了一项横断面在线调查。分别使用“改变健康的动机和态度”（MATCH）量表和糖尿病自我效能量表简版（DES-SF）分析了受访者报告的糖尿病自我效能感和健康动机的分布情况。分析了MATCH和DES-SF得分与Level2参与度指标和血糖控制之间的关联。
最终分析纳入了1258名T2D受访者（平均年龄55.7±8.4岁）。受访者的MATCH（4.19/5）和DES-SF（4.02/5）平均得分较高。意愿（4.43/5）和价值感（4.39/5）的平均MATCH子得分高于平均能力子得分（3.73/5）。MATCH和DES-SF得分与Level2参与度指标和血糖控制均显示出非常弱的相关性（ρ=-0.18-0.19）。
Level2的调查受访者平均动机和糖尿病自我效能感得分较高。需要进一步研究来验证这些量表检测动机和自我效能感随时间变化的敏感性，并确定得分差异是否可用于为人们匹配个性化干预措施。
